<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-ZWTR766V</identifier><date>2021</date><creator>Herman, Rok</creator><creator>Janež, Andrej</creator><creator>Jensterle Sever, Mojca</creator><relation>documents/doc/Z/URN_NBN_SI_doc-ZWTR766V_001.pdf</relation><relation>documents/doc/Z/URN_NBN_SI_doc-ZWTR766V_001.txt</relation><format format_type="issue">2</format><format format_type="volume">72</format><format format_type="type">article</format><format format_type="extent">str. 83-89</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">60456195</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-ZWTR766V</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Družbena omrežja</subject><subject language_type_id="slv">Farmacevtska industrija</subject><subject language_type_id="slv">Marketing</subject><subject language_type_id="slv">sladkorna bolezen</subject><subject language_type_id="slv">srčno-žilne bolezni</subject><subject language_type_id="slv">zmanjševanje tveganja za bolezni srca in ožilja</subject><title>Novel approaches to cardiovascular disease prevention in patients with type 2 diabetes</title><title>Novi pristopi preprečevanja srčno-žilnih zapletov pri bolnikih s sladkorno boleznijo tipa 2</title></Record>